SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Howard Hughes — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientHoward Hughes
Date of birth1905-12-24
IdentifiersMRN HR-ML006-SYN-TD; SSN (made up) 000-06-5571
Document date1947-05-11
AuthorAnselm Garrity-Moyo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

One-week review of contamination fears and codeine use, seen the same day by psychiatry. [S]

History of Present Illness

Mr. Hughes returns one week after intake and is seen by Dr. Bachmann-Adeyemi of psychiatry on the same day. He took his last acetaminophen-codeine tablet about 20 hours ago, as planned for starting buprenorphine today, and has taken no more than the prescribed eight tablets a day this week. He has yawning, aching, a runny nose and gooseflesh. The contamination fears and washing are unchanged, at about four hours a day; he washed his hands eleven times before coming in. He completed the PCL-5 about the crash. The intake urine test, done with his consent, was positive for codeine and morphine, as expected, and negative for fentanyl, other opioids, benzodiazepines and other drugs. The prescription monitoring report showed acetaminophen-codeine from two prescribers at two pharmacies and no other controlled drugs. HIV, hepatitis C and hepatitis B tests were negative; he is not immune to hepatitis B. He has taken his unused codeine tablets to a pharmacy take-back. [S]

ElementDetail
Last codeineAbout 20 hours ago
WithdrawalCOWS 13, moderate
RitualsAbout four hours a day; Y-BOCS 28
Intake resultsUrine positive for codeine and morphine only, negative for fentanyl; two prescribers on the monitoring report; HIV, hepatitis B and C negative; hepatitis B not immune
PCL-518, below the cut point

Review of Systems

SystemResultFinding
ConstitutionalPositiveAching and restless since this morning
GastrointestinalPositiveMild cramping; no vomiting or diarrhea
MusculoskeletalPositiveChest wall, left shoulder and low back pain
PsychiatricPositiveContamination fears and washing unchanged; no hallucinations; no thoughts of suicide or of harming anyone

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a dayOne or two tablets every 6 hours as needed, no more than 8 a dayOral route1947-05-04 to 1947-05-11completedS
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staffOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route1947-05-04activeS
Buprenorphine 2 mg with naloxone 0.5 mg sublingual film for the first day: 4 mg once withdrawal is moderate (COWS 12 or more), then 2 to 4 mg every one to two hours as needed, to no more than 16 mg on the first dayFirst-day induction by the written plan, no more than 16 mgSublingual route1947-05-11 to 1947-05-12completedS
Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain after the crash, now that codeine combination tablets have stoppedTwo tablets three times daily, no more than 3,000 mg a dayOral route1947-05-11activeS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route1947-05-11 to 1947-06-08completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1947-05-11Body height191cmS
1947-05-11Body weight72.3kgS
1947-05-11Body mass index (BMI) [Ratio]19.8kg/m2S
1947-05-11Systolic blood pressure124mm[Hg]S
1947-05-11Diastolic blood pressure80mm[Hg]S
1947-05-11Heart rate88/minS
1947-05-11Respiratory rate16/minS
1947-05-11Body temperature36.8CelS
1947-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1947-05-11PTSD PCL-5 score [PCL-5]18{score}S

Physical Exam

Vital signs recorded on 1947-05-11; see the Vital Signs section. [S]

SystemFinding
GeneralAlert, restless, yawning; blood pressure 124/80, pulse 88; weight 72.3 kg
EyesPupils 5 mm, reactive; mild tearing
SkinGooseflesh on the arms; hands red and cracked from washing; healed burn scars
MusculoskeletalTenderness over healed rib fractures on the left; left shoulder elevation limited to 120 degrees by pain
PsychiatricAnxious and courteous; contamination obsessions with washing and avoidance; says the fears are probably excessive; no psychotic features; no suicidal or homicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluationresolvedconfirmed R46.81S — Synthetic presenting problem anchored to his documented fear of germs; resolved into the diagnosis of OCD at the consultation. Not a claim about his real symptoms in 1947.
Obsessive-compulsive disorder, contamination type, with good or fair insight, not tic-related; Y-BOCS 28 (severe) at intake; no post-traumatic stress disorder on screeningactiveconfirmed F42.2S — Synthetic modern diagnosis made at the consultation, linked to the retrospective interpretation of his documented fears (R). Not a claim about his real diagnosis.
Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine plannedactiveconfirmed F11.20S — Synthetic modern coding; tolerance and withdrawal are not counted for a medicine taken under medical supervision. Person-first language; not a claim about his real diagnosis.
Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7activeconfirmed G89.21S — Synthetic modern diagnosis anchored to his documented injuries.
Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluationactiveconfirmed H91.93S — Synthetic presenting problem; resolved into a diagnosis when audiometry was done at five weeks. His documented deafness is from later years.
Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fearsactiveconfirmed R63.4S — Synthetic nutrition problem linked to the contamination fears; not a claim about his real weight in 1947.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyOCD severity (Y-BOCS, clinician-rated) and time spent on ritualsEvery visitCompleted todayY-BOCS 28 (obsessions 14, compulsions 14), confirmed by psychiatry; about four hours a day
SurveyPost-traumatic stress after the crash (PCL-5)Once, at diagnosisCompleted todayPCL-5 18, below the cut point of 31 to 33; no post-traumatic stress disorder
Medication safetySSRI tolerability and adherence: side effects, sodium, bleeding risk, activation or new suicidal thoughtsEvery visit, and two weeks after each start or dose changeCompleted todayBaseline before sertraline: sodium 139 mmol/L at intake, no anticoagulant or NSAID, no history of mania; told to report restlessness or any new thoughts of suicide
ReferralExposure and response prevention: sessions attended and home practiceWeekly, then twice weeklyOrderedWeekly sessions with the clinic psychologist booked from next week
Self-managementAccommodation by staff, reduced step by step with his consentEvery visitOrderedWritten consent signed for his assistant to join two sessions; staff will not be asked to report on him
SurveyDepression (PHQ-9) and anxiety (GAD-7)At baseline and at least monthly during acute treatmentUp to datePHQ-9 9 (item 9 scored 0) and GAD-7 12 at intake; repeat at five weeks
SurveySuicide risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or of harming anyone; 988 in his phone; codeine taken to the take-back
Self-managementOpioid use and cravings (his own account), buprenorphine adherence and side effects (sedation, constipation)Every visitCompleted todayNo more than eight codeine tablets a day this week; last dose 20 hours ago; COWS 13; buprenorphine started in clinic
LaboratoryUrine drug test with fentanyl and buprenorphine, with consentAt start, then about monthly in the first monthsUp to dateIntake test positive for codeine and morphine, negative for fentanyl, other opioids, benzodiazepines and other drugs; next at five weeks
Medication safetyPrescription drug monitoring program checkBefore every controlled-substance prescriptionCompleted todayChecked today before buprenorphine: the codeine from two prescribers seen at intake and nothing new; the other prescriber informed with his consent
Medication safetyNaloxone at home and household staff trainedEvery visitCompleted todayNaloxone at home; two of his staff shown how to use it
SurveyPain intensity and interference (PEG) and functionEvery visitUp to datePEG 6.7 at intake; repeat at five weeks
ReferralPhysical therapy and graded activityTwice weeklyOrderedPhysical therapy booked
ExaminationWeight, meals and nutritionEvery visitCompleted today72.3 kg, BMI 19.8; dietitian next week
LaboratoryKidney function, liver enzymes and albuminAt baseline and at about six months on scheduled acetaminophenUp to dateCreatinine 0.94 mg/dL, eGFR 104, urine albumin-to-creatinine ratio 8 mg/g, AST 31, ALT 38 and albumin 3.7 g/dL at intake
ImagingHearing: audiometry, hearing aids and useAudiometry once; hearing aid review after fittingOrderedAudiogram booked for the morning of the five-week visit
ReferralPsychiatry consultationAt diagnosisCompleted todaySeen by Dr. Bachmann-Adeyemi today

Goal progress:

Guideline basis: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch (March 2013): Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (Koran LM, Simpson HB), as reported by Psychiatric News (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005); CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020); Prescription Drug Monitoring Programs (PDMPs) (2026); Hearing loss in adults: assessment and management (NG98) (2018); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Telephone check tomorrow after the second day of buprenorphine. Five-week review with the audiogram that morning. Call the clinic or 988 at any time; use naloxone and call 911 for heavy sleepiness or slow breathing. Next scheduled visit 1947-06-08: five-week review: OCD treatment, buprenorphine, pain, the audiogram and weight. [S]